Cullinan oncology to participate in william blair biotech focus conference

Cambridge, mass., july 05, 2022 (globe newswire) -- cullinan oncology, inc. (nasdaq: cgem) (“cullinan”) a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today announced that its chief scientific officer, patrick baeuerle, ph.d., will deliver a keynote presentation at the william blair biotech focus conference, being held july 12-13, 2022 in new york.
CGEM Ratings Summary
CGEM Quant Ranking